<?xml version="1.0" encoding="UTF-8"?>
<fig fig-type="Figure" xml:lang="en" id="embj2020106057-fig-0005" orientation="portrait" position="float">
 <label>Figure 5</label>
 <caption>
  <title>25‐Hydrocholesterol (25
   <styled-content style="fixed-case" toggle="no">HC</styled-content>) inhibits 
   <styled-content style="fixed-case" toggle="no">SARS</styled-content>‐CoV‐2 isolate 
   <styled-content style="fixed-case" toggle="no">USA</styled-content>‐
   <styled-content style="fixed-case" toggle="no">WA</styled-content>1/2020 infection and viral entry in human lung organoids
  </title>
  <p>
   <list list-type="simple" id="embj2020106057-list-0006">
    <list-item>
     <label>A, B</label>
     <p>25HC inhibits SARS‐CoV-2 USA‐WA1/2020 strain infection in Calu‐3 cells. Cells were pretreated with ethanol or 25HC followed by infection. At 48 h post‐infection, RNA from supernatant (A) and infected cells (B) were extracted and quantified by qPCR. Data are mean ± SD of 
      <italic>n</italic> = 3, representative of 3 repeats.
     </p>
    </list-item>
    <list-item>
     <label>C</label>
     <p>Progeny virus titer in supernatant was quantified by plaque assays. Data are mean ± SD of 
      <italic>n</italic> = 3, representative of 3 repeats. *
      <italic>P</italic> &lt; 0.05, by Student's 
      <italic>t</italic>‐test.
     </p>
    </list-item>
    <list-item>
     <label>D</label>
     <p>Two‐month‐old differentiated lung organoids were pretreated with 25HC (5 μM) for 16 h and infected with luciferase‐expressing SARS‐CoV-2 pseudovirus at MOI = 0.1 for 2 h and treated with fresh medium containing 5 μM 25HC. Luciferase activity was measured at 24 h post‐infection. Mean ± SD of 
      <italic>n</italic> = 3. ****
      <italic>P &lt; </italic>0.0001, by Student's 
      <italic>t</italic>‐test.
     </p>
    </list-item>
   </list>
  </p>
 </caption>
 <graphic id="nlm-graphic-21" xlink:href="EMBJ-9999-e106057-g010" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
